Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03983954
Brief Title: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors

First Submitted : May 27, 2019
First Submitted that Met QC Criteria : June 11, 2019
First Posted : June 12, 2019

Last Update Submitted that Met QC Criteria : June 18, 2019
Last Update Posted : June 20, 2019